Albertsons Companies heads into its October 13 earnings print carrying a notable contradiction: short sellers have been adding to positions for weeks, while the company's own executives were buying stock at roughly the same prices where it trades today.
Short interest has climbed to just under 10% of the free float, reaching 54.2 million shares as of September 29. That is the highest level in the 30-day window and represents a 7.7% increase on the week and nearly 8.7% over the past month. The move follows what looks like a period of relative stability through August, with bears re-engaging sharply from late September. Despite the build, the borrow market remains relaxed. Cost to borrow is running at just 0.56%, barely changed on a weekly basis and well within normal territory. Availability of shares to borrow is ample at around 230% of current short interest, meaning there are more than two shares available to lend for every one already borrowed. There is no squeeze dynamic in this setup. The ORTEX short score, a composite of lending-market pressure and short-interest momentum, has edged up to 68.4 from 66.9 two weeks ago, placing the stock in the 10th percentile of its sector on this measure. Bears are building, but the infrastructure to support a short squeeze simply is not there.
Options traders tell a different story. The put/call ratio at 0.28 is below its 20-day average of 0.30, and the z-score of roughly minus 0.9 suggests call positioning has been running modestly above normal. That is consistent with a market pricing in some bounce potential rather than piling on alongside the shorts. The PCR has been drifting lower since mid-September, when it was closer to 0.31. Whatever the broader pessimism around the stock, the options market is not amplifying it with heavy put buying.
The Street moved decisively after the July 23 earnings print, when the stock fell 24% in a single session and shed a further 20.5% over the following five days. UBS and Citigroup both downgraded to Neutral, cutting targets to $12 and $11 respectively from $20 and $17. Goldman Sachs held its Buy rating but dropped its target to $16 from $24. JP Morgan kept Overweight at $14 down from $20. The consensus mean target now stands at $14.33 against a current price of $11.64, implying roughly 23% upside on paper, though that reflects targets set in the aftermath of a large earnings shock rather than fresh conviction. With no analyst changes in the two weeks prior to the September 14 data cut-off, the Street appears to be waiting for the October print before repositioning further. Valuation has compressed alongside: the PE ratio has fallen by roughly 0.4 turns over the past 30 days to 6.3x, and the price-to-book is down 0.2 turns over the same period to 4.1x. EV/EBITDA sits near 5.8x, broadly in line with the bull case argument around an attractive entry point.
The most pointed signal in the snapshot is the insider buying cluster that followed the July crash. CEO Susan Morris purchased 39,409 shares across two transactions on July 28 at around $11.43, spending approximately $450,000. CFO Sharon McCollam added 9,000 shares on July 31 at $11.48. EVP Thomas Moriarty made the largest single purchase, acquiring 170,500 shares on July 27 at $11.51 for just under $1.96 million. None of these were filed under a pre-arranged 10b5-1 plan, making them discretionary open-market buys. Net insider purchases over the 90-day window total 218,909 shares worth $2.5 million. The stock today at $11.64 is within cents of those purchase prices, meaning executives have not yet been rewarded for stepping in. Cerberus Capital Management, which controls a 31.3% stake and has been the dominant shareholder since before the company's IPO, reported no change in its position as of June 30. BlackRock lifted its holding to 8.1% in its most recent 13G/A filing from July 27, up from 6.9% previously. The Vanguard Group, by contrast, appears to have exited its disclosed position entirely, dropping from 7.16% to zero in its March 2026 amendment, though that stake may now sit below the 5% reporting threshold.
Wikipedia attention for Albertsons is running 1.6 standard deviations above its own 90-day baseline, a notable pickup in retail visibility for a grocery stock. That does not connect directly to the fundamental picture, but it does suggest the stock is attracting more casual scrutiny than usual, likely a function of the July sell-off's lingering profile. What the October 13 print resolves is whether the discretionary insider buying at $11.40 to $11.50 was prescient or premature: the earnings reaction history suggests this name can move violently, and with shorts at a 30-day high and a nervous Street watching for signs of stabilisation, the setup is charged in both directions.
See the live data behind this article on ORTEX.
Open ACI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
